- Trials with a EudraCT protocol (156)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
156 result(s) found for: Golimumab.
Displaying page 1 of 8.
EudraCT Number: 2019-003987-37 | Sponsor Protocol Number: 2019-001G | Start Date*: 2020-02-26 |
Sponsor Name:University Medical Centre Ljubljana, Department of gastroenterology | ||
Full Title: Exposure-response of golimumab during maintenance in ulcerative colitis: An exploratory Pharmacokinetics/Pharmacodynamics comparison of different dose regimens | ||
Medical condition: Ulcerative colitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005214-19 | Sponsor Protocol Number: S127AMCGolimumabPsA | Start Date*: 2013-06-20 |
Sponsor Name:Academic Medical Center, Department of Rheumatology | ||
Full Title: A randomized, double-blind, placebo-controlled trial of golimumab+methotrexate versus methotrexate alone in methotrexate-naïve patients with psoriatic arthritis | ||
Medical condition: active psoriatic arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001510-15 | Sponsor Protocol Number: CNTO1959UCO2002 | Start Date*: 2019-05-02 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concept Clinical Study to Evaluate the Efficacy and Safety of Combination Therapy With Guselkumab and G... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003314-39 | Sponsor Protocol Number: 78934804CRD2001 | Start Date*: 2023-02-21 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Gusel... | |||||||||||||
Medical condition: Moderately to Severely Active Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) ES (Ongoing) HU (Ongoing) NL (Ongoing) CZ (Ongoing) IT (Ongoing) AT (Ongoing) PT (Ongoing) BG (Ongoing) IE (Completed) NO (Ongoing) SI (Ongoing) SE (Ongoing) DK (Ongoing) GR (Ongoing) HR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005528-39 | Sponsor Protocol Number: 78934804UCO2001 | Start Date*: 2023-02-16 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Gusel... | |||||||||||||
Medical condition: Moderately to Severely Active Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) ES (Ongoing) HU (Ongoing) CZ (Ongoing) NL (Ongoing) SK (Ongoing) AT (Ongoing) BG (Ongoing) NO (Ongoing) IT (Ongoing) DK (Ongoing) SE (Ongoing) PT (Ongoing) SI (Ongoing) HR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004020-65 | Sponsor Protocol Number: MK-8259-038 | Start Date*: 2017-07-20 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase-IV, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of Golimumab (MK-8259 [SCH 900259]) After Treatment Withdrawal, Compared With Cont... | |||||||||||||
Medical condition: Treatment of non-radiographic axial spondyloarthritis (nr-axSpA) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) ES (Completed) NL (Completed) PL (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002458-21 | Sponsor Protocol Number: MK8259-012-00 | Start Date*: 2012-07-23 | |||||||||||
Sponsor Name:MERCK SHARP & DOHME B.V. | |||||||||||||
Full Title: Open-label, Phase 4 Study, investigating the Incidence of Extra-Articular Manifestations in Subjects with Ankylosing Spondylitis treated with Golimumab | |||||||||||||
Medical condition: Ankylosing Spondylitis (Bechterew disease) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000225-12 | Sponsor Protocol Number: CNTO148DML1001 | Start Date*: 2017-08-01 | |||||||||||
Sponsor Name:Janssen Biologics BV | |||||||||||||
Full Title: A Phase 1b Study to Evaluate SIMPONI® (golimumab) Therapy in Children, Adolescents and Young Adults with Pre-Symptomatic Type 1 Diabetes | |||||||||||||
Medical condition: A Phase 1b Study to Evaluate SIMPONI® (golimumab) Therapy in Children, Adolescents and Young Adults with Pre-Symptomatic Type 1 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001374-42 | Sponsor Protocol Number: 3573 | Start Date*: 2017-07-21 |
Sponsor Name:Guy's and St Thomas' NHS Foundation Trust | ||
Full Title: Study of the Golimumab Exposure-Response Relationship using Serum Trough Levels | ||
Medical condition: Ulcerative Colitis (UC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2006-003398-28 | Sponsor Protocol Number: C0524T17 | Start Date*: 2007-11-15 | |||||||||||
Sponsor Name:Centocor BV | |||||||||||||
Full Title: A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects with Moderat... | |||||||||||||
Medical condition: Ulcerative Colitis (UC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) AT (Completed) BE (Completed) FR (Completed) LT (Completed) LV (Completed) NL (Completed) DK (Completed) SE (Completed) BG (Completed) SK (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004101-27 | Sponsor Protocol Number: INDIGO | Start Date*: 2020-01-15 | |||||||||||||||||||||
Sponsor Name:Sint Maartenskliniek | |||||||||||||||||||||||
Full Title: INDIGO: Comparing pharmacokinetic parameters of golimumab 50 mg and golimumab 100 mg with a prolonged dose interval in patients with a rheumatic disease, a within-subject controlled study’ | |||||||||||||||||||||||
Medical condition: rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003262-25 | Sponsor Protocol Number: MK8259-022 | Start Date*: 2014-12-12 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: An open label, single group assignment design study to correlate soluble ST2 with clinical, endoscopic and histological activity in moderate to severe Ulcerative Colitis patients under golimumab | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003399-37 | Sponsor Protocol Number: C0524T18 | Start Date*: 2007-11-27 | |||||||||||
Sponsor Name:Janssen Biologics B.V. | |||||||||||||
Full Title: A Phase 3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects with Moderat... | |||||||||||||
Medical condition: Ulcerative Colitis (UC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) AT (Completed) BE (Completed) FR (Completed) LT (Completed) LV (Prematurely Ended) NL (Completed) DK (Completed) SE (Completed) BG (Completed) SK (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003397-94 | Sponsor Protocol Number: C0524T16 | Start Date*: 2007-09-05 | |||||||||||
Sponsor Name:Centocor BV | |||||||||||||
Full Title: A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects with Moderate... | |||||||||||||
Medical condition: Ulcerative Colitis (UC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) HU (Completed) AT (Prematurely Ended) BE (Completed) FR (Completed) NL (Prematurely Ended) LT (Completed) LV (Prematurely Ended) SE (Prematurely Ended) SK (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004496-31 | Sponsor Protocol Number: CNTO148UCO3003 | Start Date*: 2018-11-07 | |||||||||||
Sponsor Name:Janssen Biologics BV | |||||||||||||
Full Title: A Phase 3 Randomized, Open-Label Study to Assess the Efficacy, Safety,and Pharmacokinetics of Golimumab Treatment, a Human anti-TNFα Monoclonal Antibody, Administered Subcutaneously in Pediatric Pa... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) ES (Ongoing) FR (Ongoing) NL (Ongoing) PL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004366-18 | Sponsor Protocol Number: CNTO148UCO1001 | Start Date*: 2013-07-30 | |||||||||||
Sponsor Name:Janssen Biologics B.V. | |||||||||||||
Full Title: A Phase 1b Open-Label Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human anti-TNFα Antibody, in Pediatric Subjects with Moderately to Severely Active ... | |||||||||||||
Medical condition: Ulcerative Colitis in pediatric subjects | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) BE (Ongoing) DE (Completed) NL (Ongoing) DK (Completed) FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002579-27 | Sponsor Protocol Number: UC-GOL | Start Date*: 2015-03-03 | |||||||||||
Sponsor Name:Istituto Clinico Humanitas | |||||||||||||
Full Title: Pilot study on the efficacy of golimumab in the induction and maintenance of clinical and endoscopic remission in patients with steroid-dependent ulcerative colitis. | |||||||||||||
Medical condition: active steroid-dependent ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000643-40 | Sponsor Protocol Number: 50307 | Start Date*: 2014-01-10 | |||||||||||
Sponsor Name:Instituto de Medicina Molecular | |||||||||||||
Full Title: A multicentre, randomized, double-blind, parallel–group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy, in improving dactylitis and enthesi... | |||||||||||||
Medical condition: Psoriatic arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000152-96 | Sponsor Protocol Number: 2016-01 | Start Date*: 2019-12-16 |
Sponsor Name:GETAID | ||
Full Title: Intensive Treatment to Reach the target with Golimumab in ulcErative coliTis – In-TARGET | ||
Medical condition: Moderate to severe ulcerative colitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010582-23 | Sponsor Protocol Number: CNTO148ART3002 | Start Date*: 2010-01-04 | |||||||||||
Sponsor Name:Janssen Biologics B.V. | |||||||||||||
Full Title: A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept ... | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) AT (Completed) SE (Completed) GR (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.